Association Study of SPARCL1 Gene Polymorphisms in Ischemic Stroke

Area of Science:

• Genetics and Genomics
• Neurology
• Biomarker Discovery

Background:

• Stroke, a cerebrovascular disorder, causes significant brain damage and physical impairment.
• The hevin-calcyon protein interaction is implicated in brain injury repair.
• Secreted protein acidic and rich in cysteine-like 1 (SPARCL1) encodes the hevin protein.

Purpose of the Study:

• To investigate the association between SPARCL1 gene polymorphisms and ischemic stroke.
• To identify potential genetic biomarkers for ischemic stroke risk assessment and treatment.

Main Methods:

• A case-control study involving 509 ischemic stroke patients and 387 controls.
• Genotyping of SPARCL1 polymorphisms (rs1049544, rs1130643, rs7695558, rs1049539) using real-time polymerase chain reaction (PCR) and TaqMan™ SNP Genotyping Kit.

Main Results:

• The rs1049544 polymorphism showed a significant association with ischemic stroke prevalence.
• rs1049544 was linked to large-artery disease, and rs1130643 was associated with cardioembolism.
• Haplotype analysis revealed associations of G-G (rs1049544/rs7695558) and C-T (rs1049544/rs1049539) with ischemic stroke prevalence.

Conclusions:

• SPARCL1 gene polymorphisms are significantly associated with ischemic stroke.
• These findings suggest SPARCL1 polymorphisms as potential biomarkers for ischemic stroke risk assessment.